Methotrexate, a folate antagonist that blocks folic acid activity, is the most widely used disease-modifying antirheumatic drug for rheumatoid arthritis. It enters the cell via several pathways, one of which involves folate receptor, which is highly specific for cells present in the joints of patients with rheumatoid arthritis.
Arthritis Information
